| Net Income (Loss) per Share |
Net Income (Loss) per Share Basic net income (loss) attributable to Beneficient per common share for the years ended March 31, 2026 and 2025, is as follows: | | | | | | | | | | | | (Dollars in thousands, except per share amounts) | Year Ended March 31, | | 2026 | | 2025 | Net income (loss) | $ | (164,730) | | | $ | (803) | | Plus: Net loss attributable to noncontrolling interests | 96,222 | | 69,789 | | Less: Noncontrolling interest guaranteed payment | (18,918) | | (17,824) | Net income (loss) attributable to Beneficient common shareholders | (87,426) | | 51,162 | | Less: Net (income) loss to all participating securities | 69,140 | | — | | Net income (loss) attributable to Beneficient common shareholders | $ | (18,286) | | | $ | 51,162 | | Net income (loss) attributable to Class A common shareholders | $ | (17,661) | | | $ | 47,886 | | Net income (loss) attributable to Class B common shareholders | $ | (419) | | | $ | 3,276 | | | | | | Basic weighted average of common shares outstanding | | | | | Class A | 1,259,654 | | | 703,390 | | | Class B | 29,908 | | | 29,908 | | | | | | Basic net income (loss) attributable to Beneficient per common share | | | | | Class A | $ | (14.02) | | | $ | 68.08 | | | Class B | $ | (14.02) | | | $ | 109.54 | |
Diluted net income (loss) attributable to Beneficient per common share for the year ended March 31, 2026, is as follows: | | | | | | | | | (Dollars in thousands, except per share amounts) | | Year Ended March 31, | | | 2025 | Diluted income (loss) per share | | | | Net income (loss) attributable to Beneficient common shareholders - Basic | | $ | 51,162 | | | Adjustments for diluted EPS numerator: | | | Less: Net income (loss) attributable to noncontrolling interests - Ben | | (34,875) | | | Less: Net (income) loss to participating securities | | — | | | Plus: Noncontrolling interest guaranteed payment | | 17,824 | | | Net income (loss) attributable to Beneficient common shareholders - Diluted | | $ | 34,111 | | | | | Basic weighted average of common shares outstanding (Class A and Class B) | | 733,298 | | Dilutive effect of: | | | Series B Preferred Stock | | 81,116 | | | Class S Ordinary | | 8,373 | | | Class S Preferred | | 76 | | | Preferred Series A Subclass 0 | | 15,460,389 | | | Preferred Series A Subclass 1 | | 49,753,565 | | | | | | | | | Restricted Stock Units | | 71,334 | | | | | Diluted weighted average of common shares outstanding (Class A and Class B) | | 66,108,151 | | | | | Diluted net income (loss) attributable to Beneficient per common share (Class A and Class B) | | $ | 0.52 | |
For the year ended March 31, 2026, as the Company was in a net loss position, the diluted EPS calculation for the Beneficient common shareholders is the same as basic EPS per common share disclosed above for that period. Diluted EPS for the Class A shareholders is $(14.02) and diluted EPS for the Class B shareholders is $(14.02) for the year ended March 31, 2026. Shares of Class A Common Issued In Limited Conversion The shares of Class A Common Stock issued in the Limited Conversion are subject to forfeiture and are therefore considered contingently returnable shares. As a result, such shares are excluded from basic earnings per share until the forfeiture contingency is resolved. Because the shares are entitled to non-forfeitable dividends and undistributed earnings, they are considered participating securities, and the two-class method has been applied. For diluted earnings per share, the shares are included in the diluted share count to the extent they would remain outstanding based on the Company’s stock price at the end of the reporting period, if dilutive. In computing diluted net income (loss) per share, we considered potentially dilutive shares. Anti-dilutive shares not recognized in the diluted net loss per share calculation for the year ended March 31, 2026 and 2025, were as follows: | | | | | | | | | | | | | Shares | | Year Ended March 31, | | 2026 | | 2025 | | Series B Preferred Stock | 4,817,944 | | | — | | | Contingently Returnable Common Stock | 4,931,446 | | | — | | | Class S Ordinary | 8,376 | | | — | | | Class S Preferred | 78 | | | — | | | Preferred Series A Subclass 0 | 66,644,038 | | | — | | | Preferred Series A Subclass 1 | 208,120,305 | | | — | | | | | | | Restricted Stock Units | 172,689 | | | 33,204 | | | Stock Options | 25,000 | | | 10,719 | | | Convertible Debt | — | | | 49,248 | | | Warrants | 204,267 | | | 123,699 | | | Total anti-dilutive shares | 284,924,143 | | | 216,870 | |
Warrants The disclosed amount of anti-dilutive securities for the warrants does not consider the assumed proceeds under the treasury stock method as the exercise price was greater than the average market price of the Class A common stock, which results in negative incremental shares, that would be anti-dilutive.
|